Skip to main content

Table 1 Illness characteristics among participants in the SARS-CoV-2-positive and SARS-CoV-2-negative groups, N (%)

From: Post-recovery health domain scores among outpatients by SARS-CoV-2 testing status during the pre-Delta period

 

Positive SARS-CoV-2 result

Negative SARS-CoV-2 result

 

N

%

N

%

p-value

N

312

100

266

100

 

Total number of symptoms, mean (SD)

4.5

1.6

3.8

1.6

< 0.01

Reported symptoms at enrollment

     

 Any respiratory symptom

309

99

242

91

< 0.01

  Cough

258

83

201

76

0.03

  Loss of taste or smell

202

65

57

21

< 0.01

  Shortness of breath

124

40

82

31

0.02

  Congestion/runny nosea

212

86

164

74

< 0.01

  Sore throat

157

50

158

59

0.03

 Any generalized sign or symptom

300

96

244

92

0.01

  Fever or chills

231

74

173

65

0.02

  Fatigue

209

67

178

67

0.21

  Muscle aches

220

71

140

53

< 0.01

  Headache

247

79

182

68

< 0.01

 Any gastrointestinal symptom

166

53

126

47

0.15

  Nausea/vomiting

84

27

87

33

0.13

  Diarrhea

136

44

82

31

< 0.01

Sought subsequent medical care for illnessb

16

6

18

8

0.51

Reported recovery at 1st follow up surveyc

197

80

197

90

< 0.01

  1. SD standard deviation
  2. aNot assessed in 111 participants including 66 SARS-CoV-2 test-positive participants and 164 SARS-CoV-2 test-negative participants
  3. bWhether the participant sought medical care for their illness after enrollment as reported at the first follow-up survey. Missing for 41 SARS-CoV-2 test-negative participants and 63 SARS-CoV-2 test-positive participants. Among SARS-CoV-2-positive participants who sought additional care, 3 reported care in emergency department/hospital setting compared to 2 among test-negative participants
  4. cParticipants who responded “yes” to the question “Have you fully or mostly recovered from your illness?” on the first follow-up survey. Missing for 46 SARS-CoV-2 test-negative participants and 66 SARS-CoV-2 test-positive participants